Jussi A Hernesniemi

Summary

Affiliation: University of Tampere
Country: Finland

Publications

  1. ncbi Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--a meta
    Jussi A Hernesniemi
    Department of Clinical Chemistry, University of Tampere, Medical School, and Tampere University Hospital, Tampere, Finland
    PLoS ONE 7:e28931. 2012
  2. ncbi Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions
    J Hernesniemi
    Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital and the Medical School at the University of Tampere, Finland
    Scand J Clin Lab Invest 66:667-75. 2006
  3. ncbi Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study
    Jussi A Hernesniemi
    Laboratory of Atherosclerosis Genetics, Tampere University Hospital and Department of Clinical Chemistry, Medical School, University of Tampere, Tampere, Finland
    Atherosclerosis 196:643-9. 2008
  4. ncbi Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study
    Jussi A Hernesniemi
    Department of Clinical Chemistry, University of Tampere and Tampere University Hospital, Finland
    Atherosclerosis 198:152-9. 2008
  5. ncbi Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study
    Jussi A Hernesniemi
    Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital, Centre for Laboratory Medicine, University of Tampere, Medical School, Finn Medi 2, FI 33521 Tampere, Finland
    Eur Heart J 30:2939-46. 2009
  6. ncbi Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study
    Jussi A Hernesniemi
    Department of Clinical Chemistry, University of Tampere and Tampere University Hospital, Finland
    Ann Med 42:223-30. 2010
  7. ncbi IL-18 gene polymorphism, cardiovascular mortality and coronary artery disease
    Jussi A Hernesniemi
    Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital, Centre for Laboratory Medicine, Tampere, Finland Medical School, University of Tampere, Tampere, Finland
    Eur J Clin Invest 40:994-1001. 2010
  8. ncbi Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium
    Kari Matti Mäkelä
    Department of Clinical Chemistry, Finn Medi 2, PO Box 2000, FI 33521 Tampere, Finland
    Circ Cardiovasc Genet 6:73-81. 2013
  9. ncbi ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study
    Mari Levula
    Laboratory of Atherosclerosis Genetics, Centre for Laboratory Medicine, Tampere University Hospital and Department of Clinical Chemistry, Medical School, University of Tampere, Finland
    Ann Med 41:497-507. 2009

Collaborators

Detail Information

Publications9

  1. ncbi Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey--a meta
    Jussi A Hernesniemi
    Department of Clinical Chemistry, University of Tampere, Medical School, and Tampere University Hospital, Tampere, Finland
    PLoS ONE 7:e28931. 2012
    ..We examined whether the genetic profiling of these variants improves prediction of subclinical atherosclerosis--i.e., carotid intima-media thickness (CIMT) and carotid artery elasticity (CAE)--beyond classical risk factors...
  2. ncbi Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions
    J Hernesniemi
    Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital and the Medical School at the University of Tampere, Finland
    Scand J Clin Lab Invest 66:667-75. 2006
    ..TLR-4 is activated by, for example, lipopolysaccharides. The purpose of this study was to investigate the role of a common Asp299Gly polymorphism of the TLR-4 gene in atherosclerosis...
  3. ncbi Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study
    Jussi A Hernesniemi
    Laboratory of Atherosclerosis Genetics, Tampere University Hospital and Department of Clinical Chemistry, Medical School, University of Tampere, Tampere, Finland
    Atherosclerosis 196:643-9. 2008
    ..The C allele carriage is associated with attenuated IL-18 production. The effect of IL-18 genotype on SCD is unknown. We studied the association of the IL-18 gene -137G/C polymorphism with the occurrence of sudden cardiac death (SCD)...
  4. ncbi Toll-like receptor 4 gene (Asp299Gly) polymorphism associates with carotid artery elasticity. The cardiovascular risk in young Finns study
    Jussi A Hernesniemi
    Department of Clinical Chemistry, University of Tampere and Tampere University Hospital, Finland
    Atherosclerosis 198:152-9. 2008
    ..We wanted to examine the association of this polymorphism with carotid IMT and compliance in a population of young Finnish Caucasian adults...
  5. ncbi Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study
    Jussi A Hernesniemi
    Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital, Centre for Laboratory Medicine, University of Tampere, Medical School, Finn Medi 2, FI 33521 Tampere, Finland
    Eur Heart J 30:2939-46. 2009
    ..We examined the process by which this polymorphism alters the risk of SCD and coronary artery disease (CAD) by analysing the interactions between this polymorphism and environmental factors...
  6. ncbi Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study
    Jussi A Hernesniemi
    Department of Clinical Chemistry, University of Tampere and Tampere University Hospital, Finland
    Ann Med 42:223-30. 2010
    ....
  7. ncbi IL-18 gene polymorphism, cardiovascular mortality and coronary artery disease
    Jussi A Hernesniemi
    Laboratory of Atherosclerosis Genetics, Department of Clinical Chemistry, Tampere University Hospital, Centre for Laboratory Medicine, Tampere, Finland Medical School, University of Tampere, Tampere, Finland
    Eur J Clin Invest 40:994-1001. 2010
    ....
  8. ncbi Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium
    Kari Matti Mäkelä
    Department of Clinical Chemistry, Finn Medi 2, PO Box 2000, FI 33521 Tampere, Finland
    Circ Cardiovasc Genet 6:73-81. 2013
    ..We performed a genome-wide association study on oxidized low-density lipoprotein and tested the impact of associated single-nucleotide polymorphisms (SNPs) on the risk factors of atherosclerosis and cardiovascular events...
  9. ncbi ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study
    Mari Levula
    Laboratory of Atherosclerosis Genetics, Centre for Laboratory Medicine, Tampere University Hospital and Department of Clinical Chemistry, Medical School, University of Tampere, Finland
    Ann Med 41:497-507. 2009
    ..Previously, we scanned all 23,000 human genes for differential expression between normal and atherosclerotic tissues and found the involvement of ADAM8...